BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35884755)

  • 1. Magnetic Resonance Planimetry in the Differential Diagnosis between Parkinson's Disease and Progressive Supranuclear Palsy.
    Quattrone A; Morelli M; Bianco MG; Buonocore J; Sarica A; Caligiuri ME; Aracri F; Calomino C; De Maria M; Vaccaro MG; Gramigna V; Augimeri A; Vescio B; Quattrone A
    Brain Sci; 2022 Jul; 12(7):. PubMed ID: 35884755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
    Heim B; Mangesius S; Krismer F; Wenning GK; Hussl A; Scherfler C; Gizewski ER; Schocke M; Esterhammer R; Quattrone A; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2021 Jan; 82():87-91. PubMed ID: 33271461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of magnetic resonance planimetry and magnetic resonance parkinsonism index in discriminating Parkinson's disease and progressive supranuclear palsy: a retrospective study based on 1.5 and 3 T MRI.
    Nizamani WM; Mubarak F; Barakzai MD; Ahmed MS
    Int J Gen Med; 2017; 10():375-384. PubMed ID: 29184432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
    Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
    Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR planimetry in neurodegenerative parkinsonism yields high diagnostic accuracy for PSP.
    Mangesius S; Hussl A; Krismer F; Mahlknecht P; Reiter E; Tagwercher S; Djamshidian A; Schocke M; Esterhammer R; Wenning G; Müller C; Scherfler C; Gizewski ER; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2018 Jan; 46():47-55. PubMed ID: 29126761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of optimal value of magnetic resonance planimetry and the parkinsonism index for the diagnosis of Parkinson's disease and progressive supranuclear palsy.
    Shetty N; Koteshwar P; Priyanka
    J Taibah Univ Med Sci; 2023 Dec; 18(6):1577-1585. PubMed ID: 37701844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
    Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
    Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
    Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI measurements of brainstem structures in patients with vascular parkinsonism, progressive supranuclear palsy, and Parkinson's disease.
    Kim BC; Choi SM; Choi KH; Nam TS; Kim JT; Lee SH; Park MS; Yoon W
    Neurol Sci; 2017 Apr; 38(4):627-633. PubMed ID: 28078564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease.
    Zhang K; Liang Z; Wang C; Zhang X; Yu B; Liu X
    Parkinsonism Relat Disord; 2019 Sep; 66():176-181. PubMed ID: 31420309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midbrain MRI assessments in progressive supranuclear palsy subtypes.
    Picillo M; Tepedino MF; Abate F; Erro R; Ponticorvo S; Tartaglione S; Volpe G; Frosini D; Cecchi P; Cosottini M; Ceravolo R; Esposito F; Pellecchia MT; Barone P; Manara R
    J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):98-103. PubMed ID: 31527182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.
    Archer DB; Mitchell T; Burciu RG; Yang J; Nigro S; Quattrone A; Quattrone A; Jeromin A; McFarland NR; Okun MS; Vaillancourt DE
    Mov Disord; 2020 Aug; 35(8):1388-1395. PubMed ID: 32357259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.
    Quattrone A; Morelli M; Vescio B; Nigro S; Le Piane E; Sabatini U; Caracciolo M; Vescio V; Quattrone A; Barbagallo G; Stanà C; Nicoletti G; Arabia G; Nisticò R; Novellino F; Salsone M
    Mov Disord; 2019 Apr; 34(4):487-495. PubMed ID: 30759325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Performance of the Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease: An Updated Systematic Review and Meta-Analysis.
    Kim S; Suh CH; Shim WH; Kim SJ
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.